B-type natriuretic peptide clinical activation in aortic stenosis: Impact on long-term survival

Journal of the American College of Cardiology

Volumn 63, Issue 19, 2014, Pages 2016-2025

  Clavel, Marie Annick ^a   Malouf, Joseph ^a   Michelena, Hector I ^a   Suri, Rakesh M ^a   Jaffe, Allan S ^a   Mahoney, Douglas W ^a   Enriquez Sarano, Maurice ^a  

^a MAYO CLINIC   (United States)

Author keywords

aortic stenosis; Doppler echocardiography; natriuretic peptide; valvular heart disease

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE; AGED; AORTA STENOSIS; ARTICLE; BRAIN NATRIURETIC PEPTIDE BLOOD LEVEL; BRAIN NATRIURETIC PEPTIDE CLINICAL ACTIVATION; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GENDER; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SURVIVAL RATE; SYMPTOMATOLOGY; AORTA VALVE REPLACEMENT; CARDIOVASCULAR MORTALITY; OVERALL SURVIVAL; PREDICTIVE VALUE; SURVIVAL PREDICTION; SURVIVAL TIME;

AORTIC STENOSIS; DOPPLER ECHOCARDIOGRAPHY; NATRIURETIC PEPTIDE; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84900548982     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.02.581     Document Type: Article

References (47)

1. B.P. Shapiro, H.H. Chen, J.C. Burnett Jr., and M.M. Redfield Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure Mayo Clin Proc 78 2003 481 486
2. S.Q. Khan, O. Dhillon, and D. Kelly et al. Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study J Am Coll Cardiol 51 2008 1857 1864
3. E. Di Angelantonio, R. Chowdhury, and N. Sarwar et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies Circulation 120 2009 2177 2187
4. D.R. Pu, J.R. Chiong, and Q.C. Zhou Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases Heart Fail Rev 15 2010 293 304
5. S.G. Ray Natriuretic peptides in heart valve disease Heart 92 2006 1194 1197
6. I.L. Gerber, R.A. Stewart, and M.E. Legget et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis Circulation 107 2003 1884 1890
7. J. Bergler-Klein, U. Klaar, and M. Heger et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308
8. N. Iwahashi, S. Nakatani, S. Umemura, K. Kimura, and M. Kitakaze Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis J Am Soc Echocardiogr 24 2011 984 991
9. M. Katz, F. Tarasoutchi, and A.E. Pesaro et al. Natriuretic peptides and long-term mortality in patients with severe aortic stenosis J Heart Valve Dis 21 2012 331 336
10. J. Bergler-Klein, G. Mundigler, and P. Pibarot et al. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study Circulation 115 2007 2848 2855
11. C. Cimadevilla, C. Cueff, and G. Hekimian et al. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study Heart 99 2013 461 467
12. P. Lim, J.L. Monin, and M. Monchi et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide Eur Heart J 25 2004 2048 2053
13. M.G. Nessmith, H. Fukuta, S. Brucks, and W.C. Little Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery Am J Cardiol 96 2005 1445 1448
14. R.O. Bonow, B.A. Carabello, and C. Kanu et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J Am Coll Cardiol 48 2006 e1 e148
15. A. Vahanian, O. Alfieri, and F. Andreotti et al. Guidelines on the management of valvular heart disease (version 2012) Eur Heart J 33 2012 2451 2496
16. V.T. Nkomo, J.M. Gardin, T.N. Skelton, J.S. Gottdiener, C.G. Scott, and M. Enriquez-Sarano Burden of valvular heart diseases: a population-based study Lancet 368 2006 1005 1011
17. B. Iung, G. Baron, and E.G. Butchart et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease Eur Heart J 24 2003 1231 1243
18. J. Ross Jr., and E. Braunwald Aortic stenosis Circulation 38 1968 61 67
19. C.M. Otto Calcific aortic valve disease: outflow obstruction is the end stage of a systemic disease process Eur Heart J 30 2009 1940 1942
20. J. Malouf, T. Le Tourneau, and P. Pellikka et al. Aortic valve stenosis in community medical practice: determinants of outcome and implications for aortic valve replacement J Thorac Cardiovasc Surg 144 2012 1421 1427
21. D. Detaint, D. Messika-Zeitoun, and J.F. Avierinos et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome Circulation 111 2005 2391 2397
22. A. Rossi, M. Enriquez-Sarano, J.C. Burnett Jr., A. Lerman, M.D. Abel, and J.B. Seward Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study J Am Coll Cardiol 35 2000 1256 1262
23. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
24. R.A. Nishimura, F.A. Miller Jr., M.J. Callahan, R.C. Benassi, J.B. Seward, and A.J. Tajik Doppler echocardiography: theory, instrumentation, technique, and application Mayo Clin Proc 60 1985 321 343
25. H. Baumgartner, J. Hung, and J. Bermejo et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice J Am Soc Echocardiogr 22 2009 1 23
26. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, D.W. Mahoney, K.R. Bailey, and J.C. Burnett Jr. Plasma brain natriuretic peptide concentration: impact of age and gender J Am Coll Cardiol 40 2002 976 982
27. M.J. Devivo, A.T. Underhill, and P.R. Fine Accuracy of world-wide-web death searches for persons with traumatic brain injury Brain Inj 18 2004 1155 1162
28. J. Quinn, N. Kramer, and D. McDermott Validation of the Social Security Death Index (SSDI): an important readily-available outcomes database for researchers West J Emerg Med 9 2008 6 8
29. C.M. Wei, D.M. Heublein, and M.A. Perrella et al. Natriuretic peptide system in human heart failure Circulation 88 1993 1004 1009
30. D. Detaint, D. Messika-Zeitoun, and H.H. Chen et al. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation Am J Cardiol 97 2006 1029 1034
31. R.D. Kociol, J.R. Horton, and G.C. Fonarow et al. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) linked to Medicare claims Circ Heart Fail 4 2011 628 636
32. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
33. R. Pizarro, O.O. Bazzino, and P.F. Oberti et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation J Am Coll Cardiol 54 2009 1099 1106
34. J.L. Monin, P. Lancellotti, and M. Monchi et al. Risk score for predicting outcome in patients with asymptomatic aortic stenosis Circulation 120 2009 69 75
35. F.S. Apple, M. Panteghini, and J. Ravkilde et al. Quality specifications for B-type natriuretic peptide assays Clin Chem 51 2005 486 493
36. M.B. Leon, C.R. Smith, and M. Mack et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
37. P.A. Pellikka, R.A. Nishimura, K.R. Bailey, and A.J. Tajik The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis J Am Coll Cardiol 15 1990 1012 1017
38. C.M. Otto, I.G. Burwash, and M.E. Legget et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome Circulation 95 1997 2262 2270
39. R. Rosenhek, T. Binder, and G. Porenta et al. Predictors of outcome in severe, asymptomatic aortic stenosis N Engl J Med 343 2000 611 617
40. P.A. Pellikka, M.E. Sarano, and R.A. Nishimura et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up Circulation 111 2005 3290 3295
41. R.G. Pai, N. Kapoor, R.C. Bansal, and P. Varadarajan Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement Ann Thorac Surg 82 2006 2116 2122
42. P. Das, H. Rimington, and J. Chambers Exercise testing to stratify risk in aortic stenosis Eur Heart J 26 2005 1309 1313
43. A. Dhoble, M.E. Sarano, S.L. Kopecky, R.J. Thomas, C.L. Hayes, and T.G. Allison Safety of symptom-limited cardiopulmonary exercise testing in patients with aortic stenosis Am J Med 125 2012 704 708
44. F. Weidemann, S. Herrmann, and S. Stork et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis Circulation 120 2009 577 584
45. P. Lancellotti, M. Moonen, and J. Magne et al. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis Am J Cardiol 105 2010 383 388
46. S. Herrmann, S. Stork, and M. Niemann et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome J Am Coll Cardiol 58 2011 402 412
47. S.H. Poulsen, P. Sogaard, J.E. Nielsen-Kudsk, and H. Egeblad Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides J Am Soc Echocardiogr 20 2007 877 884